THE VERTICAL CHAIN OF RESEARCH AND DEVELOPMENT IN THE PHARMACEUTICAL INDUSTRY
- 1 January 1995
- journal article
- Published by Wiley in Economic Inquiry
- Vol. 33 (1) , 70-87
- https://doi.org/10.1111/j.1465-7295.1995.tb01847.x
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Do Important Drugs Reach the Market Sooner?The RAND Journal of Economics, 1994
- Cost of innovation in the pharmaceutical industryJournal of Health Economics, 1991
- Regulation and Firm Size: FDA Impacts on InnovationThe RAND Journal of Economics, 1990
- Costs of Production, Intra- and Interindustry R&D Spillovers: Canadian EvidenceCanadian Journal of Economics/Revue canadienne d'économique, 1988
- A bibliometric analysis of pharmaceutical researchResearch Policy, 1983
- Product Quality Regulation and New Drug Introductions: Some New Evidence from the 1970sThe Review of Economics and Statistics, 1981
- Estimating the Effects of Regulation on Innovation: An International Comparative Analysis of the Pharmaceutical IndustryThe Journal of Law and Economics, 1978
- Toward a More General Theory of RegulationThe Journal of Law and Economics, 1976
- Research and Development Costs and Returns: The U.S. Pharmaceutical IndustryJournal of Political Economy, 1972
- Information and Efficiency: Another ViewpointThe Journal of Law and Economics, 1969